Topotecan alleviates ventilator-induced lung injury via NF-κB pathway inhibition

被引：12

作者：

Wan, Bing ^{[1
,2
]}

Xu, Wu-jian ^{[1
]}

Zhan, Ping ^{[1
]}

Jin, Jia-jia ^{[1
]}

Xi, Guang-min ^{[1
]}

Chen, Mei-zi ^{[1
]}

Hu, Yang-bo ^{[1
]}

Zhu, Su-hua ^{[1
]}

Liu, Hong-bing ^{[1
]}

Wang, Xiao-xia ^{[1
]}

Zhang, Xiu-wei ^{[2
]}

Lv, Tang-feng ^{[1
]}

Song, Yong ^{[1
]}

机构：

[1] Southern Med Univ Guangzhou, Nanjing Clin Sch, Jinling Hosp, Dept Resp & Crit Med, Nanjing 210002, Jiangsu, Peoples R China

[2] Nanjing Med Univ, Affiliated Jiangning Hosp, Dept Resp Med, Nanjing 210002, Jiangsu, Peoples R China

来源：

CYTOKINE | 2018年 / 110卷

基金：

中国国家自然科学基金;

关键词：

Ventilator-induced lung injury; Topotecan; Nuclear factor-kappa B (NF-kappa B); RESPIRATORY-DISTRESS-SYNDROME; NEUTROPHILIC INFLAMMATION; CANCER; CELLS; MODEL; ACTIVATION; EXPRESSION; ALPHA;

D O I：

10.1016/j.cyto.2018.04.016

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Objective: We investigated the effect of topotecan on injury and inflammation in a model of ventilator-induced lung injury (VILI). Methods: Acute lung injury (ALI) was induced in mice by high-tidal volume ventilation, and the mice were then treated with topotecan or PBS. Lung tissue and bronchoalveolar lavage fluid were collected to assess pulmonary vascular leaks, inflammation, and cell apoptosis. Results: Compared to PBS treatment, topotecan significantly decreased the ALI score, myeloperoxidase (MPO) content, total protein concentration, and presence of inflammatory cells and inflammatory cytokines in bronchoalveolar lavage fluid. Topotecan also reduced caspase-3 activation and type II alveolar epithelial cell apoptosis. Moreover, topotecan inhibited NF-kappa B expression and activation in the VILI model. Conclusion: Topotecan alleviates acute lung injury in the model of VILI through the inhibition of the NF-kappa B pathway.

引用

页码：381 / 388

页数：8

共 37 条

[1] Albensi BC, 2000, SYNAPSE, V35, P151
[2] Southwest Oncology Group S0802: A Randomized, Phase II Trial of Weekly Topotecan With and Without Ziv-Aflibercept in Patients With Platinum-Treated Small-Cell Lung Cancer
Allen, Jeffrey W.
Moon, James
Redman, Mary
Gadgeel, Shirish M.
Kelly, Karen
Mack, Philip C.
Saba, Hanna M.
Mohamed, Mohamed K.
Jahanzeb, Mohammad
Gandara, David R.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (23) : 2463 - 2470
[3] RANK-ligand (RANKL) expression in young breast cancer patients and during pregnancy
Azim, Hatem A., Jr.
Peccatori, Fedro A.
Brohee, Sylvain
Branstetter, Daniel
Loi, Sherene
Viale, Giuseppe
Piccart, Martine
Dougall, William C.
Pruneri, Giancarlo
Sotiriou, Christos
[J]. BREAST CANCER RESEARCH, 2015, 17
[4] The NF-κB regulatory network
Brasier, Allan R.
[J]. CARDIOVASCULAR TOXICOLOGY, 2006, 6 (02) : 111 - 130
[5] Ocular Salvage and Vision Preservation Using a Topotecan-Based Regimen for Advanced Intraocular Retinoblastoma
Brennan, Rachel C.
Qaddoumi, Ibrahim
Mao, Shenghua
Wu, Jianrong
Billups, Catherine A.
Stewart, Clinton F.
Hoehn, Mary Ellen
Rodriguez-Galindo, Carlos
Wilson, Matthew W.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (01) : 72 - +
[6] Is Extracorporeal Circulation the Future of Acute Respiratory Distress Syndrome Management?
Combes, Alain
Pesenti, Antonio
Ranieri, V. Marco
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195 (09) : 1161 - 1170
[7] Ventilator-induced lung injury: historical perspectives and clinical implications
de Prost, Nicolas
Ricard, Jean-Damien
Saumon, Georges
Dreyfuss, Didier
[J]. ANNALS OF INTENSIVE CARE, 2011, 1
[8] Novel approaches to minimize ventilator-induced lung injury
Fan, Eddy
Villar, Jesus
Slutsky, Arthur S.
[J]. BMC MEDICINE, 2013, 11
[9] Human immunodeficiency virus-1 Tat activates NF-κB via physical interaction with IκB-α and p65
Fiume, Giuseppe
Vecchio, Eleonora
De Laurentiis, Annamaria
Trimboli, Francesca
Palmieri, Camillo
Pisano, Antonio
Falcone, Cristina
Pontoriero, Marilena
Rossi, Annalisa
Scialdone, Annarita
Masci, Francesca Fasanella
Scala, Giuseppe
Quinto, Ileana
[J]. NUCLEIC ACIDS RESEARCH, 2012, 40 (08) : 3548 - 3562
[10] Introduction to NF-κB:: players, pathways, perspectives
Gilmore, T. D.
[J]. ONCOGENE, 2006, 25 (51) : 6680 - 6684

← 1 2 3 4 →